IN8bio Inc.

NASDAQ: INAB
Share price (3/28/25): $0.20
Market cap (3/28/25): $15.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Shelf registration

Exempt offering of securities

Prospectus supplement for primary offering

Ownership Filter

Ho William Tai-Wei

Alyeska Investment Group, L.P.

News Filter

Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights

Change in Directors, Officers or Compensation

Announces Advanced Gamma-Delta (Gd) T Cell Engager (TCE) Platform for Oncology and Autoimmune Diseases

Reports Updated Positive Results From Phase 1 Trial of INB-100 in Leukemia Patients

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Shareholder Nominations

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission